Increase of plasma insulin by racecadotril, an inhibitor of enkephalinase, in wistar rats

H. T. Wu, C. K. Chang, K. C. Cheng, C. H. Chang, C. H. Yeh, J. T. Cheng

研究成果: 雜誌貢獻文章

7 引文 (Scopus)

摘要

Racecadotril is known as an inhibitor of enkephalinase. Increase of plasma insulin by racecadotril has been observed in rats while the mechanism of the action remains obscure. In the present study, intravenous injection of male Wistar rats with racecadotril significantly decreased blood glucose levels. However, this effect of racecadotril was not modified by naloxone at the dose sufficient to block opioid receptors. Thus, the blood glucose-lowering action of racecadotril might be through an endogenous opioid independent mechanism. Otherwise, we found that C-peptide content was also raised by racecadotril in parallel with the increase of insulin in Wistar rats. Thus, the blood glucose-lowering action of racecadotril was related to insulin secretion, but not through the inhibition of plasma insulin degradation. In addition, racecadotril showed no direct effect on insulin secretion in isolated islets or cultured HIT-T15 cells. The increase of plasma insulin and blood glucose-lowering action induced by racecadotril were reduced by pretreatment with atropine and enhanced by physotigmine. Direct inhibition of cholinesterase was not observed in brain homogenates treated with racecadotril. Moreover, actions of racecadotril were significantly reduced in rats receiving hemicholinium-3 at a sufficient dose to decrease endogenous acetylcholine. Activation of cholinergic tone is possibly involved in the blood glucose-lowering effect of racecadotril. Our results suggested that racecadotril increased insulin secretion to lower blood glucose mainly via regulation of parasympathetic tone in Wistar rats.
原文英語
頁(從 - 到)261-267
頁數7
期刊Hormone and Metabolic Research
42
發行號4
DOIs
出版狀態已發佈 - 2010

指紋

Neprilysin
Wistar Rats
Rats
Insulin
Plasmas
Blood Glucose
racecadotril
Hemicholinium 3
C-Peptide
Cholinesterases
Opioid Receptors
Naloxone
Atropine
Intravenous Injections
Cholinergic Agents
Opioid Analgesics
Acetylcholine
Brain

ASJC Scopus subject areas

  • Biochemistry
  • Endocrinology
  • Clinical Biochemistry
  • Biochemistry, medical
  • Endocrinology, Diabetes and Metabolism

引用此文

Increase of plasma insulin by racecadotril, an inhibitor of enkephalinase, in wistar rats. / Wu, H. T.; Chang, C. K.; Cheng, K. C.; Chang, C. H.; Yeh, C. H.; Cheng, J. T.

於: Hormone and Metabolic Research, 卷 42, 編號 4, 2010, p. 261-267.

研究成果: 雜誌貢獻文章

Wu, H. T. ; Chang, C. K. ; Cheng, K. C. ; Chang, C. H. ; Yeh, C. H. ; Cheng, J. T. / Increase of plasma insulin by racecadotril, an inhibitor of enkephalinase, in wistar rats. 於: Hormone and Metabolic Research. 2010 ; 卷 42, 編號 4. 頁 261-267.
@article{5def656be1ac442ab51986c741f0729d,
title = "Increase of plasma insulin by racecadotril, an inhibitor of enkephalinase, in wistar rats",
abstract = "Racecadotril is known as an inhibitor of enkephalinase. Increase of plasma insulin by racecadotril has been observed in rats while the mechanism of the action remains obscure. In the present study, intravenous injection of male Wistar rats with racecadotril significantly decreased blood glucose levels. However, this effect of racecadotril was not modified by naloxone at the dose sufficient to block opioid receptors. Thus, the blood glucose-lowering action of racecadotril might be through an endogenous opioid independent mechanism. Otherwise, we found that C-peptide content was also raised by racecadotril in parallel with the increase of insulin in Wistar rats. Thus, the blood glucose-lowering action of racecadotril was related to insulin secretion, but not through the inhibition of plasma insulin degradation. In addition, racecadotril showed no direct effect on insulin secretion in isolated islets or cultured HIT-T15 cells. The increase of plasma insulin and blood glucose-lowering action induced by racecadotril were reduced by pretreatment with atropine and enhanced by physotigmine. Direct inhibition of cholinesterase was not observed in brain homogenates treated with racecadotril. Moreover, actions of racecadotril were significantly reduced in rats receiving hemicholinium-3 at a sufficient dose to decrease endogenous acetylcholine. Activation of cholinergic tone is possibly involved in the blood glucose-lowering effect of racecadotril. Our results suggested that racecadotril increased insulin secretion to lower blood glucose mainly via regulation of parasympathetic tone in Wistar rats.",
keywords = "C-peptide, Cholinesterase, HIT-T15 -cells, Insulin release, Parasympathetic nerve, Racecadotril",
author = "Wu, {H. T.} and Chang, {C. K.} and Cheng, {K. C.} and Chang, {C. H.} and Yeh, {C. H.} and Cheng, {J. T.}",
year = "2010",
doi = "10.1055/s-0029-1246190",
language = "English",
volume = "42",
pages = "261--267",
journal = "Hormone and Metabolic Research",
issn = "0018-5043",
publisher = "Georg Thieme Verlag",
number = "4",

}

TY - JOUR

T1 - Increase of plasma insulin by racecadotril, an inhibitor of enkephalinase, in wistar rats

AU - Wu, H. T.

AU - Chang, C. K.

AU - Cheng, K. C.

AU - Chang, C. H.

AU - Yeh, C. H.

AU - Cheng, J. T.

PY - 2010

Y1 - 2010

N2 - Racecadotril is known as an inhibitor of enkephalinase. Increase of plasma insulin by racecadotril has been observed in rats while the mechanism of the action remains obscure. In the present study, intravenous injection of male Wistar rats with racecadotril significantly decreased blood glucose levels. However, this effect of racecadotril was not modified by naloxone at the dose sufficient to block opioid receptors. Thus, the blood glucose-lowering action of racecadotril might be through an endogenous opioid independent mechanism. Otherwise, we found that C-peptide content was also raised by racecadotril in parallel with the increase of insulin in Wistar rats. Thus, the blood glucose-lowering action of racecadotril was related to insulin secretion, but not through the inhibition of plasma insulin degradation. In addition, racecadotril showed no direct effect on insulin secretion in isolated islets or cultured HIT-T15 cells. The increase of plasma insulin and blood glucose-lowering action induced by racecadotril were reduced by pretreatment with atropine and enhanced by physotigmine. Direct inhibition of cholinesterase was not observed in brain homogenates treated with racecadotril. Moreover, actions of racecadotril were significantly reduced in rats receiving hemicholinium-3 at a sufficient dose to decrease endogenous acetylcholine. Activation of cholinergic tone is possibly involved in the blood glucose-lowering effect of racecadotril. Our results suggested that racecadotril increased insulin secretion to lower blood glucose mainly via regulation of parasympathetic tone in Wistar rats.

AB - Racecadotril is known as an inhibitor of enkephalinase. Increase of plasma insulin by racecadotril has been observed in rats while the mechanism of the action remains obscure. In the present study, intravenous injection of male Wistar rats with racecadotril significantly decreased blood glucose levels. However, this effect of racecadotril was not modified by naloxone at the dose sufficient to block opioid receptors. Thus, the blood glucose-lowering action of racecadotril might be through an endogenous opioid independent mechanism. Otherwise, we found that C-peptide content was also raised by racecadotril in parallel with the increase of insulin in Wistar rats. Thus, the blood glucose-lowering action of racecadotril was related to insulin secretion, but not through the inhibition of plasma insulin degradation. In addition, racecadotril showed no direct effect on insulin secretion in isolated islets or cultured HIT-T15 cells. The increase of plasma insulin and blood glucose-lowering action induced by racecadotril were reduced by pretreatment with atropine and enhanced by physotigmine. Direct inhibition of cholinesterase was not observed in brain homogenates treated with racecadotril. Moreover, actions of racecadotril were significantly reduced in rats receiving hemicholinium-3 at a sufficient dose to decrease endogenous acetylcholine. Activation of cholinergic tone is possibly involved in the blood glucose-lowering effect of racecadotril. Our results suggested that racecadotril increased insulin secretion to lower blood glucose mainly via regulation of parasympathetic tone in Wistar rats.

KW - C-peptide

KW - Cholinesterase

KW - HIT-T15 -cells

KW - Insulin release

KW - Parasympathetic nerve

KW - Racecadotril

UR - http://www.scopus.com/inward/record.url?scp=77950470891&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77950470891&partnerID=8YFLogxK

U2 - 10.1055/s-0029-1246190

DO - 10.1055/s-0029-1246190

M3 - Article

VL - 42

SP - 261

EP - 267

JO - Hormone and Metabolic Research

JF - Hormone and Metabolic Research

SN - 0018-5043

IS - 4

ER -